Windtree Therapeutics implements BNB treasury strategy worth 200 million USD
Windtree Therapeutics, a US-listed biotechnology company on Nasdaq, has announced plans to implement a crypto treasury strategy focused on
$BNB , with a total potential investment of up to 200 million USD. The company has signed an investment agreement of 60 million USD with Build and Build Corp and may raise an additional 140 million USD.
Pioneering the BNB Treasury strategy in the US
The funds raised will be used to purchase and hold BNB, build a secure custody infrastructure, and generate returns from this token. If approved by shareholders,
#Windtree will become the first Nasdaq-listed company to directly own BNB, marking a "revolutionary" step according to CEO Jed Latkin.
Windtree's move has been described by Patrick Horsman, CEO of Build and Build Corp, as "breakthrough and very timely," helping investors access Binance and BNB in a mainstream manner. The founder of Binance, Changpeng Zhao (CZ), also expressed excitement. Windtree's investment also includes shares of Osprey BNB Chain Trust, a trust fund that allows investors to access BNB in the form of traditional securities.
Windtree believes that accumulating BNB not only provides financial growth potential but also helps the company enter the rapidly growing blockchain sector, especially as the regulatory environment in the US becomes more open. This trend is spreading, with YZi Labs and Nano Labs also actively buying BNB. Immediately following this news, Windtree's stock price (WINT) surged more than 8.62%, and the price of BNB also slightly increased by 3.4%, reaching 710 USD.
#anhbacong